Brand Insights - Thought Leadership / Paid Program | CoverMyMeds
Integrating strategies for patient and professional support may enable more enlightening conversations between patients and providers, thus positively impacting both patient adherence and health outcomes
Your specialty therapies aren’t just going from Point A to Point B. Your partner in 3PL should be able to customize solutions to meet your specific demands.
Issues include apparently diverted opioids and mislabeled medications
Already-built Las Colinas facility will be the global headquarters in April 2019
Current McKesson president, Brian Tyler, will take over in April 2019
Biologics, RxCrossroads units will retain their identity
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
3
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
4
Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial
5
